🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
The objective of the study is the evaluation of efficacy and safety of obin...
Status
Terminated
Location
Centrum Onkologii - Instytut im. Marii Skłodowskiej- Curie Klinika Nowotworów Układu Chłonnego
Start Date
2018-05-14
Trial ID
NCT03229382
Treatments Being Tested
This is a phase I single center dose escalation study with an extension at ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-11-08
Trial ID
NCT01634217
Treatments Being Tested
This is a single-arm, open label, phase 1 study in subjects with beta-thala...
Status
Recruiting
Location
Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University
Start Date
2024-10-01
Trial ID
NCT06734520
Treatments Being Tested
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
Combination use of darbepoetin and G-CSF will improve left ventricular syst...
Status
Unknown
Location
Seoul National Univesity Hospital
Start Date
2007-03
Trial ID
NCT00501917
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749